Kazutoshi Isobe

2.0k total citations
109 papers, 926 citations indexed

About

Kazutoshi Isobe is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Kazutoshi Isobe has authored 109 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 19 papers in Surgery. Recurrent topics in Kazutoshi Isobe's work include Lung Cancer Treatments and Mutations (35 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers) and Lung Cancer Diagnosis and Treatment (20 papers). Kazutoshi Isobe is often cited by papers focused on Lung Cancer Treatments and Mutations (35 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers) and Lung Cancer Diagnosis and Treatment (20 papers). Kazutoshi Isobe collaborates with scholars based in Japan, United States and Australia. Kazutoshi Isobe's co-authors include Sakae Homma, Susumu Sakamoto, Yujiro Takai, Kazutoshi Shibuya, Keishi Sugino, Yoshinobu Hata, Go Sano, Fumiaki Ishida, Hajime Otsuka and Akira Iyoda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kazutoshi Isobe

99 papers receiving 915 citations

Peers

Countries citing papers authored by Kazutoshi Isobe

Since Specialization

Citations

This map shows the geographic impact of Kazutoshi Isobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazutoshi Isobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazutoshi Isobe more than expected).

Fields of papers citing papers by Kazutoshi Isobe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazutoshi Isobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazutoshi Isobe. The network helps show where Kazutoshi Isobe may publish in the future.

Co-authorship network of co-authors of Kazutoshi Isobe

This figure shows the co-authorship network connecting the top 25 collaborators of Kazutoshi Isobe. A scholar is included among the top collaborators of Kazutoshi Isobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazutoshi Isobe. Kazutoshi Isobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and Immune-Related Adverse Events of Immune Checkpoint Inhibitors in Patients With Non-small Cell Lung Cancer and Autoimmune Diseases 2025 ·Cureus ·(unknown), Kazutoshi Isobe, (unknown), Kaichi Kaneko, Atsuhito Saiki, (unknown)	0
2	A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A 2024 ·ESMO Open ·Atsuto Mouri, (unknown), (unknown), Ryo Ko, (unknown), Tomonori Makiguchi, Kazutoshi Isobe, (unknown), Toru Kondo, Minoru Akiyama, Akihiro Bessho, (unknown), Kazuya Yoshimura, Hiroshi Kagamu, Shingo Kato, Kunihiko Kobayashi, (unknown), Makoto Maemondo	1
3	Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia 2024 ·ERJ Open Research ·Kazutoshi Isobe, Yasuhiko Nakamura, Susumu Sakamoto, Keisuke Tomii, Takayuki Takimoto, Yasunari Miyazaki, Masaru Matsumoto, Keishi Sugino, Kazuya Ichikado, (unknown), Kakuhiro Yamaguchi, Tomohisa Baba, Hiroaki Ozasa, (unknown), (unknown), Sakae Homma, Hiroshi Date, Takafumi Suda, Kazuma Kishi	4
4	A retrospective study of 157 patients comparing platinum-anthracycline to other platinum combination for untreated unresectable thymoma: NEJ023B. 2024 ·Journal of Clinical Oncology ·Go Saito, Ryo Ko, Yuki Shiko, Yoshiaki Nagai, Risa Ebina‐Shibuya, Kazutoshi Isobe, Kazuhiro Nishiyama, (unknown), (unknown), (unknown), (unknown), Kyoichi Kaira, Yoshiro Nakahara, (unknown), Hiromi Nagashima, (unknown), (unknown), Makoto Maemondo, Kunihiko Kobayashi, Takehito Shukuya	0
5	Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non–small Cell Lung Cancer: TORG1937 (DATE Study) 2024 ·Clinical Cancer Research ·Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi, Tetsuro Kondo, Shuji Murakami, Yoshimasa Shiraishi, Hisao Imai, Daijiro Harada, Kazutoshi Isobe, (unknown), Saori Takata, (unknown), (unknown), Satoshi Ikeda, Tetsuhiko Asao, Naoki Furuya, Shinobu Hosokawa, (unknown), Yuichi Takiguchi, Hiroaki Okamoto	8
6	Extended 73‐month survival in an elderly patient with BRAF V600E‐mutated lung adenocarcinoma: A case report 2024 ·SHILAP Revista de lepidopterología ·Kensuke Namba, Kazutoshi Isobe, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Nobuyuki Hiruta, Yasuo Matsuzawa	0
7	1294P A final analysis of a phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non–small-cell lung cancer: TORG1937 (DATE study) 2023 ·Annals of Oncology ·Tetsuro Kondo, Kaoru Kubota, Shinji Nakamichi, Toshihiro Misumi, Shuji Murakami, Yoshimasa Shiraishi, Hisao Imai, Daijiro Harada, Kazutoshi Isobe, (unknown), Saori Takata, Hiroshi Wakui, (unknown), Satoshi Ikeda, Tetsuhiko Asao, Naoki Furuya, Shinobu Hosokawa, Yumiko Kobayashi, Yuichi Takiguchi, Hiroaki Okamoto	1
8	Entrectinib‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1‐rearranged non‐small cell lung cancer 2023 ·SHILAP Revista de lepidopterología ·Chiaki Kato, (unknown), (unknown), (unknown), Takahiro Yoshizawa, Kazutoshi Isobe, Naobumi Tochigi, Kazutoshi Shibuya, Kazuma Kishi	1
9	New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis 2022 ·Scientific Reports ·Susumu Sakamoto, Hiroshige Shimizu, Takuma Isshiki, Yasuhiko Nakamura, (unknown), Atsuko Kurosaki, Kazutoshi Isobe, Yujiro Takai, Sakae Homma	10
10	Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan 2021 ·Diabetes Metabolic Syndrome and Obesity ·(unknown), Hiroshi Uchino, (unknown), Masahiko Miyagi, (unknown), (unknown), Kazutoshi Isobe, Kazuma Kishi, Sakae Homma, Takahisa Hirose	6
11	Association of BIM Deletion Polymorphism and BIM-γ RNA Expression in NSCLC with EGFR Mutation 2016 ·Cancer Genomics & Proteomics ·Kazutoshi Isobe, (unknown), Tetsuo Mikami, (unknown), Hiroshi Kobayashi, Takahiro Yoshizawa, Takashi Makino, Hajime Otsuka, Go Sano, Keishi Sugino, Susumu Sakamoto, Yujiro Takai, Naobumi Tochigi, Akira Iyoda, Sakae Homma	9
12	Predicted extracapsular invasion of hilar lymph node metastasis by fusion positron emission tomography/computed tomography in patients with lung cancer 2015 ·Molecular and Clinical Oncology ·Takashi Makino, Yoshinobu Hata, Hajime Otsuka, Satoshi Koezuka, Kazutoshi Isobe, (unknown), Nobuyuki Shiraga, Kazutoshi Shibuya, Sakae Homma, Akira Iyoda	1
13	Clinical Significance of BIM Deletion Polymorphism in Non–Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation 2014 ·Journal of Thoracic Oncology ·Kazutoshi Isobe, Yoshinobu Hata, Naobumi Tochigi, (unknown), Hiroshi Kobayashi, Takashi Makino, Hajime Otsuka, (unknown), Fumiaki Ishida, Naoshi Kikuchi, (unknown), Keita Sato, Go Sano, Keishi Sugino, Susumu Sakamoto, Yujiro Takai, Kazutoshi Shibuya, Akira Iyoda, Sakae Homma	60
14	A Prospective PCR-Based Screening for the EML4-ALK Oncogene in Non–Small Cell Lung Cancer 2012 ·Clinical Cancer Research ·Manabu Soda, Kazutoshi Isobe, Akira Inoue, Makoto Maemondo, Satoshi Oizumi, Yuka Fujita, Akihiko Gemma, Yoshihiro Yamashita, Toshihide Ueno, Kengo Takeuchi, Young Lim Choi, Hitoshi Miyazawa, Tomoaki Tanaka, Koichi Hagiwara, Hiroyuki Mano, (unknown)	96
15	Two Cases of Ileal Metastases from Primary Lung Cancer 2010 ·Haigan ·(unknown), Kazutoshi Isobe, Shinji Sakaguchi, Susumu Sakamoto, Kazutoshi Shibuya, Sakae Homma	1
16	A Case of Choroidal Metastasis as an Initial Manifestation of Lung Cancer Successfully Treated with Gefitinib 2008 ·Haigan ·Shinji Sakaguchi, Kazutoshi Isobe, Nobuyuki Hamanaka, (unknown), Keita Sato, Sakae Homma	2
17	[Usefulness of FDG-PET for the diagnosis of postoperative recurrence of lung cancer]. 2007 ·PubMed ·Kazutoshi Isobe, Keigo Takagi, Yoshinobu Hata, Nobuyuki Hamanaka, Kunihiko Shimizu, Kazuhiro Kimura, (unknown), (unknown), Sakae Homma	1
18	A case of bronchioloalveolar carcinoma with a large pulmonary cavity of 10cm in diameter 2007 ·The Journal of the Japanese Association for Chest Surgery ·(unknown), Yoshinobu Hata, Chikako Hasegawa, (unknown), (unknown), Kazutoshi Isobe, Kazutoshi Shibuya, Keigo Takagi	1
19	Clinical Characteristics of Acute Exacerbation of Interstitial Pneumonia Associated with Lung Cancer After Anti-cancer Treatment 2007 ·Haigan ·Kazutoshi Isobe, Yoshinobu Hata, Keishi Sugino, Go Sano, Yujiro Takai, Kazuhiro Kimura, Chikako Hasegawa, (unknown), Keigo Takagi, Sakae Homma	5
20	A Case of Small Cell Lung Cancer with Metastasis to the Stomach Diagnosed Under FDG-PET 2006 ·Haigan ·(unknown), Kazutoshi Isobe, Kunihiko Shimizu, Kazuhiro Kimura, Chikako Hasegawa, Sakae Homma	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact